Score Overview
Explore the 2021 public Archive ranking →
Where Enanta Pharmaceuticals Inc has ranked, year by year
Showing 5 years ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- ENTA
2019: 22.0% · 2021: 95.5% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-10-01 | $ 12.84 | — |
1 Year2025-10-01 | $ 10.61 | 21.02% |
5 Years2021-10-01 | $ 60.96 | -78.94% |
10 Years2016-09-30 | $ 26.61 | -51.75% |
All Time2013-03-21 | $ 17.18 | -25.26% |
| Period | Last Price2026-10-01 | 1 Year2025-10-01 | 5 Years2021-10-01 | 10 Years2016-09-30 | All Time2013-03-21 |
|---|---|---|---|---|---|
| Price | $ 12.84 | $ 10.61 | $ 60.96 | $ 26.61 | $ 17.18 |
| Return | — | 21.02% | -78.94% | -51.75% | -25.26% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 65M | -$ 63M | $ 189M |
| 2025 | $ 65M | -$ 81M | $ 188M |
| 2024 | $ 67M | -$ 116M | $ 248M |
| 2023 | $ 79M | -$ 133M | $ 369M |
| 2022 | $ 86M | -$ 121M | $ 249M |
| 2021 | $ 97M | -$ 78M | $ 244M |
| 2020 | $ 122M | -$ 36M | $ 386M |
| 2019 | $ 205M | $ 46M | $ 335M |
| 2018 | $ 206M | $ 71M | $ 308M |
| 2017 | $ 102M | $ 17M | $ 223M |
| 2016 | $ 88M | $ 21M | $ 210M |
| 2015 | $ 160M | $ 78M | $ 145M |
| 2014 | $ 47M | $ 34M | $ 90M |
| IPO2013 | $ 32M | $ 9M | $ 101M |
Enanta Pharmaceuticals Inc fundamental performance
Between 2020 and 2025, revenue declined from $ 122M to $ 65M and net income went from -$ 36M to -$ 81M. Revenue increased in 0 of those 5 years; net income in 3.
Between 2015 and 2025, revenue declined from $ 160M to $ 65M and net income went from $ 78M to -$ 81M. Revenue increased in 2 of those 10 years; net income in 4.
Enanta Pharmaceuticals Inc currently holds a 5-year HDB Score of 3.7 out of 10. How the HDB Score is calculated.
Membership
Continue ENTA’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,813 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
